Frequency and Magnitude of Interferon β Neutralizing Antibodies in the Evaluation of Interferon β Immunogenicity in Patients with Multiple Sclerosis-Reference-Cited by-同舟云学术

Frequency and Magnitude of Interferon β Neutralizing Antibodies in the Evaluation of Interferon β Immunogenicity in Patients with Multiple Sclerosis

Published:2011-03 Issue:3 Volume:31 Page:337-344
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Grossberg Sidney E.¹²,Oger Joel³,Grossberg Leslie D.¹,Gehchan Adel⁴,Klein John P.⁵

Affiliation:

1. Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin.

2. Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

3. Neuro-Immunology Laboratory and Multiple Sclerosis Clinic, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

4. Biogen Idec Canada, Toronto, Canada.

5. Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2010.0038

Reference44 articles.

1. Regional variation of multiple sclerosis prevalence in Canada

2. Immunogenicity of interferon beta: differences among products

3. Reduced effectiveness of long-term interferon-β treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study

4. Optimisation of the Cellular Metabolism of Glycosylation for Recombinant Proteins Produced by Mammalian Cell Systems

5. A randomized, double-blind, dose-comparison study of weekly interferon -1a in relapsing MS

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment;Frontiers in Immunology;2021-05-25

2. Glycosylation Heterogeneity of Hyperglycosylated Recombinant Human Interferon-β (rhIFN-β);ACS Omega;2020-03-20

3. Multiplexed Gene Expression as a Characterization of Bioactivity for Interferon Beta (IFN-β) Biosimilar Candidates: Impact of Innate Immune Response Modulating Impurities (IIRMIs);The AAPS Journal;2019-02-08

4. Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge;Expert Review of Clinical Immunology;2018-01-23

5. Protein Particulates and Biosimilar Development: Analytical Tools and Therapeutic Implications;Biosimilars;2018